X @Bloomberg

Sarepta Therapeutics(US:SRPT) Bloomberg·2025-07-28 20:54

In a major win for Sarepta, US regulators are recommending that patients who can walk be allowed to take its gene therapy Elevidys again https://t.co/lnGkzEsubE ...